211 related articles for article (PubMed ID: 22628229)
41. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
42. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
43. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
[TBL] [Abstract][Full Text] [Related]
44. Identification of proteomic signatures associated with lung cancer and COPD.
Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
[TBL] [Abstract][Full Text] [Related]
45. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
[TBL] [Abstract][Full Text] [Related]
46. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma.
Liu C; Pan C; Wang H; Yong L
Tumour Biol; 2011 Dec; 32(6):1139-45. PubMed ID: 21826475
[TBL] [Abstract][Full Text] [Related]
47. Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer.
Lu ZL; Chen YJ; Jing XY; Wang NN; Zhang T; Hu CJ
Med Sci Monit; 2018 Mar; 24():1581-1587. PubMed ID: 29549708
[TBL] [Abstract][Full Text] [Related]
48. Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads.
Wu S; Xu K; Chen G; Zhang J; Liu Z; Xie X
Int J Clin Oncol; 2012 Apr; 17(2):89-95. PubMed ID: 21638024
[TBL] [Abstract][Full Text] [Related]
49. [Identification of serum peptide biomarker for ovarian cancer diagnosis by Clin-TOF-II-MS combined with magnetic beads technology].
Xiu L; Li N; Wang WP; Chen F; Yuan GW; Sun YC; Zhang R; Li XG; Zuo J; Li N; Cui W; Wu LY
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1188-1195. PubMed ID: 34794222
[No Abstract] [Full Text] [Related]
50. [Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry].
Gao BX; Li MX; Liu XJ; Cai JF; Fan XH; Yang XL; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):511-6. PubMed ID: 22338134
[TBL] [Abstract][Full Text] [Related]
51. Identification of novel serum biomarkers for gastric cancer by magnetic bead.
Liu W; Gao X; Cai Q; Li J; Zhu Z; Li C; Yao X; Yang Q; Xiang M; Yan M; Zhu Z
Front Biosci (Elite Ed); 2010 Jun; 2(3):961-71. PubMed ID: 20515767
[TBL] [Abstract][Full Text] [Related]
52. Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.
Tao YL; Li Y; Gao J; Liu ZG; Tu ZW; Li G; Xu BQ; Niu DL; Jiang CB; Yi W; Li ZQ; Li J; Wang YM; Cheng ZB; Liu QD; Bai L; Zhang C; Zhang JY; Zeng MS; Xia YF
J Cell Biochem; 2012 Jul; 113(7):2268-78. PubMed ID: 22334501
[TBL] [Abstract][Full Text] [Related]
53. Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
Wang L; Tang C; Xu B; Yang L; Qu L; Li L; Li X; Wang W; Qin H; Gao H; He K; Liu X
PLoS One; 2017; 12(6):e0179000. PubMed ID: 28594947
[TBL] [Abstract][Full Text] [Related]
54. Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.
Sui W; Huang L; Dai Y; Chen J; Yan Q; Huang H
Clin Exp Med; 2010 Dec; 10(4):259-68. PubMed ID: 20376689
[TBL] [Abstract][Full Text] [Related]
55. Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.
Jin Y; Yang Y; Su Y; Ye X; Liu W; Yang Q; Wang J; Fu X; Gong Y; Sun H
Glycoconj J; 2019 Feb; 36(1):57-68. PubMed ID: 30607521
[TBL] [Abstract][Full Text] [Related]
56. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
Hortin GL
Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
[TBL] [Abstract][Full Text] [Related]
57. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
[TBL] [Abstract][Full Text] [Related]
58. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
59. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
Liu C; Pan C; Shen J; Wang H; Yong L
Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
[TBL] [Abstract][Full Text] [Related]
60. Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads.
Ma D; Liang N; Zhang L
Front Med (Lausanne); 2021; 8():609773. PubMed ID: 33718399
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
